Retractable Technologies (RVP) said Tuesday it was no longer pursuing a case in the US Court of International Trade against defendants involved in the issuance of a 100% tariff on syringes and needles imported from China.
The complaint was dismissed Wednesday last week, the company said.
Although the tariffs were allegedly not properly implemented, the company said it was withdrawing the complaint because it did not see itself prevailing "against the interests of a large monopolistic corporation."
The company further said that it also saw a lower risk of tariffs hurting its business after its engineers were able to enhance the transition process, significantly reducing the need to import syringes.
Price: 0.74, Change: -0.01, Percent Change: -1.50
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.